Kain Capital
Kain Capital is a healthcare-focused growth private equity firm partnering with founder-led mid-sized healthcare companies across five subsectors, deploying proprietary technology enablement through Kain Analytics to drive value-based care transformation.
- Company typePrivate
- Founded2015
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Kain Capital does
Kain Capital is a New York-based private equity firm founded in 2015 by Kunal Kain that invests growth equity in founder-led, mid-sized U.S. healthcare companies with $20-150M+ in revenue and $5-40M in EBITDA. The firm targets five subsectors — primary care/multi-specialty, hospice/palliative care, diagnostic services, occupational medicine, and specialty behavioral health (autism therapy) — and typically takes control positions of 60-85% or protected minority positions of 20-49%, partnering with entrepreneurs who remain actively involved post-close.
The firm's defining feature is its technology enablement platform, Kain Analytics, a wholly-owned subsidiary launched in September 2024. Kain Analytics builds and deploys Python-based ETL pipelines, machine learning models (including CNNs, LLMs, and predictive analytics), NLP for clinical notes, and Power BI dashboards that consolidate payer data, EHR data (Epic, eClinicalWorks), and CMS claims into operational modules such as a Care Gaps framework, HCC recapture and risk-based contract management, risk stratification, payer transparency analytics, and operational/clinical intelligence. The firm also incubated Agenta Health, an agentic AI patient engagement platform combining inbound/outbound voice, text, and AI video, which was sold to Arbiter in 2025. Infrastructure runs on Azure and AWS with SQL Server, Plotly Dash, and Power BI for visualization.
Kain Capital generates revenue primarily through management fees and carried interest from healthcare-focused investment funds, with Kain Analytics providing a secondary stream of professional services revenue to portfolio companies. As of mid-2026, the portfolio includes MY DR NOW ($60M cumulative investment), Essen Health Care, Excelsior/Rendr, RadX Inc., White Wilson Medical Center, Luminos Hospice, Agile Occupational Medicine, ChenMed, MDLand, and an autism therapy platform — collectively spanning more than a dozen U.S. states. The firm is preparing for its inaugural institutional fund and has expanded leadership with senior hires including a CTO (Ashish Gupta, ex-Google ML lead), CFO/CCO (Bret Cummings), General Counsel (Solomon Eskinazi), and additional partners and VPs to support that launch.
Kain Capital firmographics
Firmographics- Name
- Kain Capital
- Legal name
- Kain Capital, LLC
- Website
- https://kaincap.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kain Capital is a healthcare-focused growth private equity firm partnering with founder-led mid-sized healthcare companies across five subsectors, deploying proprietary technology enablement through Kain Analytics to drive value-based care transformation.
- Ownership category
- akta.pro rank
Kain Capital industry classification
Industry- Product category
- Healthcare Private Equity / Growth Equity Investing
- NAICS
- Portfolio Management and Investment Advice (523940), Management of Companies and Enterprises (55111)
- SIC
- Investors, Nec (6799), Finance Services (6199)
- akta.pro primary industry
- Technology & Software Growth Equity (FSANACAA)
Keywords
Where Kain Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Kain Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Private Equity Fund Management: Kain Capital operates as a private equity firm managing healthcare-focused investment funds. Revenue is generated through management fees and carried interest from portfolio company exits. The firm's investor base is comprised predominantly of long-term capital, permitting a patient approach to investing not tied to any specific return horizon.
- Technology Enablement Services: Kain Analytics, a subsidiary of Kain Capital, provides technology, data science and AI solutions to portfolio companies, generating service revenue through hands-on tech implementation including data stack development, value-based care quality pipelines, and technology consulting.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Kain Capital product offering
Product offeringCore offering
Kain Capital is a private equity firm that makes growth equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, typically taking control positions (60-85%) or protected minority positions (20-49%). The firm pairs capital with hands-on operational and technology enablement through its Kain Analytics subsidiary, which deploys proprietary AI/ML, data warehousing, and analytics modules to help portfolio companies transition to value-based care.
Product overview
Kain Capital operates as a private equity firm focused on healthcare services and technology-enabled healthcare companies. The firm's technology arm, Kain Analytics, provides centralized AI, data science, and workflow automation solutions across the portfolio. The product suite includes Agenta Health (AI-powered patient engagement platform), CMS Caregaps and Quality tracking, HCC Recapture and opportunity detection, Risk Stratification, Predictive Analytics for value-based care, Operational/Clinical Intelligence dashboards, and Payer Transparency analytics. These modules work together to enable portfolio companies' transition to value-based care through integrated EHR data processing, risk scoring, care gap management, and population health analytics.
Differentiator
Problem solved
Functional benefit
Products and services
- Kain Analytics Technology, data science, and AI subsidiary of Kain Capital that delivers centralized analytics, workflow automation, and custom-built implementations for healthcare portfolio companies, including EHR integration, value-based care pipelines, care gap and HCC management, risk stratification, predictive analytics, operational dashboards, and payer transparency tooling.
- Healthcare Growth Equity Investments Growth equity private equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, paired with operational support, senior management recruitment, strategic M&A, and Kain Analytics technology enablement to accelerate organic growth and transition portfolio companies to value-based care.
Quantifiable outcome
- 80-90% of manual patient engagement calls automated through Agenta Health AI platform
- +6 more outcomes
Companies that use Kain Capital
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
Kain Capital technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature7 records
Kain Capital partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ArbitercoreAgenta Health, the AI innovation arm of Kain Analytics, was sold to Arbiter in 2025. Arbiter is a care orchestration platform unifying patients, providers, and payers on one intelligent system, leveraging Agenta's agentic technology for patient, provider, and plan engagement. Agenta's technology now powers Arbiter's broader care orchestration mission.
Scale indicators5 records
Recent moves9 records
Expansion highlights6 records
Kain Capital competitors and assessment
Company assessmentDirect peers
- Chicago Pacific Founders: Healthcare-focused growth equity firm investing in lower middle market healthcare services and technology-enabled care companies. Highly comparable to Kain: similar mid-sized founder-led thesis, sector overlap in primary care and physician groups, and overlapping team pedigree (Kain Partner Sameer Mathur joined from Chicago Pacific Founders).
- DW Healthcare Partners: Lower middle market healthcare PE firm focused exclusively on healthcare services, healthcare IT, and medical products across North America. Directly comparable to Kain on sector exclusivity, deal-size sweet spot, and the operational/value-creation playbook. Kain Partner Sameer Mathur also previously worked at DW Healthcare Partners.
- Linden Capital Partners: Healthcare-only middle-market PE firm making control and growth investments in healthcare services and products. Closely comparable to Kain on sector focus, equity check size range, and founder-friendly partnership orientation.
- Welsh, Carson, Anderson & Stowe: One of the longest-tenured healthcare-focused PE firms, investing across healthcare services, technology, and information services. Larger and more established than Kain but competes in the same sector and many of the same subsectors (physician groups, value-based care, healthcare IT).
- New Mountain Capital: Healthcare-focused growth equity firm with significant activity in healthcare services, payer-services, and tech-enabled care. Comparable to Kain on healthcare-services emphasis and growth equity orientation, though at substantially larger fund sizes.
- Health Enterprise Partners: Growth equity firm investing in lower middle market healthcare services and information technology companies. Highly comparable to Kain on healthcare-only mandate, mid-market check size, and tech-enabled services focus.
- Audax Group: Middle-market PE firm with an active healthcare vertical that pursues control investments in founder-led healthcare services companies. Comparable to Kain on mid-sized founder-led thesis, healthcare services focus, and add-on roll-up strategy.
Broad incumbents
- TPG Capital: Large diversified alternative asset manager with a dedicated TPG Healthcare strategy that invests across healthcare services, pharma, and medtech. Competes with Kain for larger healthcare-services deals and provides a comparison point on scale and resources versus a focused mid-market specialist.
- Bain Capital Private Equity (Healthcare): Global PE platform with a dedicated Bain Capital Life Sciences / healthcare services practice that invests across the healthcare value chain. Comparable as a competitor for mid- and upper-mid healthcare services opportunities, though operating at substantially larger scale than Kain.
Emerging players
- Copley Equity Partners: Lower middle market PE firm investing in healthcare services, consumer, and B2B services companies. Smaller and earlier-stage than Kain but a relevant peer on healthcare services focus and lower-middle-market deal zone.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kain Capital social profiles
Digital presenceKain Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kain Capital leadership team
Management profileNumber of profiles
Profiles12 records
Kain Capital subsidiaries and ownership
Company hierarchySubsidiaries4 records
Kain Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kain Capital M&A and investment
M&A and investmentM&A3 records
Investments5 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kain Capital
What does Kain Capital do?
Kain Capital is a private equity firm that makes growth equity investments in founder-led, mid-sized U.S. healthcare services and technology-enabled healthcare companies, typically taking control positions (60-85%) or protected minority positions (20-49%). The firm pairs capital with hands-on operational and technology enablement through its Kain Analytics subsidiary, which deploys proprietary AI/ML, data warehousing, and analytics modules to help portfolio companies transition to value-based care.
Is Kain Capital a public or private company?
Kain Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Kain Capital founded?
Kain Capital was founded in 2015. It employs 11 to 50 people.
Where is Kain Capital based?
Kain Capital is headquartered in New York, United States, in the North America region.
How does Kain Capital make money?
Two revenue lines are on record. Private Equity Fund Management is the primary driver. The others are technology Enablement Services.
Who are Kain Capital's main competitors?
Direct peers on record are Chicago Pacific Founders, DW Healthcare Partners, Linden Capital Partners, Welsh, Carson, Anderson & Stowe, New Mountain Capital, Health Enterprise Partners and Audax Group. Broad incumbents are TPG Capital and Bain Capital Private Equity (Healthcare). Copley Equity Partners is listed as an emerging player.
Does Kain Capital have an API?
No public API is recorded for Kain Capital.
What industry is Kain Capital in?
Kain Capital's product category is Healthcare Private Equity / Growth Equity Investing. Its primary akta.pro industry code is FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6799.